Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Laura Chico is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/17/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/11/2024 | VIGL | Buy Now | Vigil Neuroscience | $4.22 | 445.02% | $23 → $23 | Reiterates | Outperform → Outperform | Get Alert |
| 07/11/2024 | STOK | Buy Now | Stoke Therapeutics | $14.74 | 15.33% | $17 → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 06/28/2024 | VIGL | Buy Now | Vigil Neuroscience | $4.22 | 445.02% | $22 → $23 | Maintains | Outperform | Get Alert |
| 06/26/2024 | EWTX | Buy Now | Edgewise Therapeutics | $22.20 | 39.64% | $31 → $31 | Reiterates | Outperform → Outperform | Get Alert |
| 06/06/2024 | AVTE | Buy Now | Aerovate Therapeutics | $1.98 | 1970.71% | $41 → $41 | Reiterates | Outperform → Outperform | Get Alert |
| 05/31/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $45.27 | 6.03% | $47 → $48 | Maintains | Neutral | Get Alert |
| 05/29/2024 | NBIX | Buy Now | Neurocrine Biosciences | $146.02 | 4.1% | → $152 | Reiterates | Outperform → Outperform | Get Alert |
| 05/24/2024 | ARDX | Buy Now | Ardelyx | $6.17 | 143.11% | → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 05/22/2024 | AVTE | Buy Now | Aerovate Therapeutics | $1.98 | 1970.71% | → $41 | Reiterates | Outperform → Outperform | Get Alert |
| 05/15/2024 | PEPG | Buy Now | PepGen | $18.00 | 11.11% | → $20 | Reiterates | Outperform → Outperform | Get Alert |
| 05/14/2024 | AVTE | Buy Now | Aerovate Therapeutics | $1.98 | 1970.71% | → $41 | Reiterates | Outperform → Outperform | Get Alert |
| 05/14/2024 | VYGR | Buy Now | Voyager Therapeutics | $9.09 | -11.99% | $10 → $8 | Maintains | Neutral | Get Alert |
| 05/10/2024 | ATXS | Buy Now | Astria Therapeutics | $11.84 | 85.81% | → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2024 | DNTH | Buy Now | Dianthus Therapeutics | $28.50 | 33.33% | $33 → $38 | Maintains | Outperform | Get Alert |
| 05/10/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $42.94 | 16.44% | $51 → $50 | Maintains | Outperform | Get Alert |
| 05/09/2024 | PHVS | Buy Now | Pharvaris | $16.65 | 86.19% | $35 → $31 | Maintains | Outperform | Get Alert |
| 05/08/2024 | GOSS | Buy Now | Gossamer Bio | $1.24 | 222.58% | → $4 | Reiterates | Outperform → Outperform | Get Alert |
| 05/08/2024 | VIGL | Buy Now | Vigil Neuroscience | $4.22 | 421.33% | → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 05/08/2024 | DNLI | Buy Now | Denali Therapeutics | $23.94 | 25.31% | $31 → $30 | Maintains | Outperform | Get Alert |
| 05/03/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | $39.50 | -13.92% | $32 → $34 | Maintains | Outperform | Get Alert |
| 05/03/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $45.27 | 3.82% | $48 → $47 | Maintains | Neutral | Get Alert |
| 05/03/2024 | ARDX | Buy Now | Ardelyx | $6.17 | 143.11% | $14 → $15 | Maintains | Outperform | Get Alert |
| 04/25/2024 | BIIB | Buy Now | Biogen | $225.02 | -4.45% | $213 → $215 | Maintains | Neutral | Get Alert |
| 04/17/2024 | NBIX | Buy Now | Neurocrine Biosciences | $146.02 | 0.67% | → $147 | Reiterates | Outperform → Outperform | Get Alert |
| 04/17/2024 | TVTX | Buy Now | Travere Therapeutics | $10.22 | 27.2% | → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 04/17/2024 | SAGE | Buy Now | Sage Therapeutics | $12.16 | 97.37% | → $24 | Reiterates | Neutral → Neutral | Get Alert |
| 04/17/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $45.27 | 6.03% | → $48 | Reiterates | Neutral → Neutral | Get Alert |
| 04/17/2024 | BIIB | Buy Now | Biogen | $225.02 | -5.34% | $245 → $213 | Maintains | Neutral | Get Alert |
| 04/17/2024 | ARDX | Buy Now | Ardelyx | $6.17 | 126.9% | $13 → $14 | Maintains | Outperform | Get Alert |
| 04/17/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $40.04 | 42.37% | $67 → $57 | Maintains | Neutral | Get Alert |
| 04/16/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $45.27 | 6.03% | → $48 | Reiterates | Neutral → Neutral | Get Alert |
| 04/16/2024 | EWTX | Buy Now | Edgewise Therapeutics | $22.20 | 17.12% | → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 04/11/2024 | PHVS | Buy Now | Pharvaris | $16.65 | 110.21% | → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 04/11/2024 | RLYB | Buy Now | Rallybio | $1.47 | 648.25% | $13 → $11 | Maintains | Outperform | Get Alert |
| 04/05/2024 | GOSS | Buy Now | Gossamer Bio | $1.24 | 222.58% | → $4 | Assumes | → Outperform | Get Alert |
| 04/05/2024 | OVID | Buy Now | Ovid Therapeutics | $1.04 | 669.23% | → $8 | Initiates | → Outperform | Get Alert |
| 03/26/2024 | STOK | Buy Now | Stoke Therapeutics | $14.74 | 15.33% | $13 → $17 | Maintains | Outperform | Get Alert |
| 03/26/2024 | ATXS | Buy Now | Astria Therapeutics | $11.84 | 85.81% | → $17 | Maintains | Outperform | Get Alert |
| 03/22/2024 | DNTH | Buy Now | Dianthus Therapeutics | $28.50 | 15.79% | $24 → $33 | Maintains | Outperform | Get Alert |
| 03/21/2024 | VERA | Buy Now | Vera Therapeutics | $38.19 | -10.97% | $21 → $34 | Maintains | Neutral | Get Alert |
| 03/20/2024 | DSGN | Buy Now | Design Therapeutics | $4.55 | 9.89% | → $5 | Reiterates | Neutral → Neutral | Get Alert |
| 03/19/2024 | PHVS | Buy Now | Pharvaris | $16.65 | 110.21% | → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 03/13/2024 | LBPH | Buy Now | Longboard Pharmaceuticals | $39.50 | -18.99% | → $32 | Reiterates | Outperform → Outperform | Get Alert |
| 03/07/2024 | PEPG | Buy Now | PepGen | $18.00 | 11.11% | $21 → $20 | Maintains | Outperform | Get Alert |
| 03/05/2024 | ATXS | Buy Now | Astria Therapeutics | $11.84 | 43.58% | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 03/01/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $42.94 | 18.77% | $46 → $51 | Maintains | Outperform | Get Alert |
| 02/28/2024 | VRDN | Buy Now | Viridian Therapeutics | $15.97 | 150.47% | $39 → $40 | Maintains | Outperform | Get Alert |
| 02/28/2024 | DNLI | Buy Now | Denali Therapeutics | $23.94 | 29.49% | → $31 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $40.04 | 67.35% | $60 → $67 | Maintains | Neutral | Get Alert |
| 02/23/2024 | ARDX | Buy Now | Ardelyx | $6.17 | 110.7% | → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 02/16/2024 | TVTX | Buy Now | Travere Therapeutics | $10.22 | 27.2% | → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 02/16/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $45.27 | 6.03% | $47 → $48 | Maintains | Neutral | Get Alert |
| 02/07/2024 | RLYB | Buy Now | Rallybio | $1.47 | 784.29% | $14 → $13 | Maintains | Outperform | Get Alert |
| 01/30/2024 | PEPG | Buy Now | PepGen | $18.00 | 16.67% | → $21 | Reiterates | Outperform → Outperform | Get Alert |
| 01/30/2024 | ATXS | Buy Now | Astria Therapeutics | $11.84 | 43.58% | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 01/26/2024 | DNTH | Buy Now | Dianthus Therapeutics | $28.50 | -15.79% | $23 → $24 | Maintains | Outperform | Get Alert |
| 01/26/2024 | VERA | Buy Now | Vera Therapeutics | $38.19 | -45.01% | $16 → $21 | Maintains | Neutral | Get Alert |
| 01/12/2024 | ARDX | Buy Now | Ardelyx | $6.17 | 110.7% | $9 → $13 | Maintains | Outperform | Get Alert |
| 01/12/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $40.04 | 49.87% | $39 → $60 | Maintains | Neutral | Get Alert |
| 01/12/2024 | PRAX | Buy Now | Praxis Precision Medicine | $53.12 | -45.41% | $16 → $29 | Maintains | Neutral | Get Alert |
| 12/22/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | → $330 | Downgrade | Outperform → Neutral | Get Alert |
| 12/04/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.97 | 131.68% | → $37 | Reiterates | Outperform → Outperform | Get Alert |
| 12/01/2023 | ARDX | Buy Now | Ardelyx | $6.17 | 45.87% | → $9 | Reiterates | Outperform → Outperform | Get Alert |
| 11/22/2023 | DNTH | Buy Now | Dianthus Therapeutics | $28.50 | -19.3% | → $23 | Initiates | → Outperform | Get Alert |
| 11/17/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | → $253 | Reiterates | Outperform → Outperform | Get Alert |
| 11/17/2023 | VIGL | Buy Now | Vigil Neuroscience | $4.22 | 445.02% | → $23 | Reiterates | Outperform → Outperform | Get Alert |
| 11/10/2023 | EWTX | Buy Now | Edgewise Therapeutics | $22.20 | 3.6% | $27 → $23 | Maintains | Outperform | Get Alert |
| 11/10/2023 | RLYB | Buy Now | Rallybio | $1.47 | 852.32% | $16 → $14 | Maintains | Outperform | Get Alert |
| 11/09/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $42.94 | 7.13% | $47 → $46 | Maintains | Outperform | Get Alert |
| 11/09/2023 | BIIB | Buy Now | Biogen | $225.02 | 6.21% | $266 → $239 | Maintains | Neutral | Get Alert |
| 11/08/2023 | VIGL | Buy Now | Vigil Neuroscience | $4.22 | 445.02% | → $23 | Reiterates | Outperform → Outperform | Get Alert |
| 11/08/2023 | SAGE | Buy Now | Sage Therapeutics | $12.16 | 80.92% | $21 → $22 | Maintains | Neutral | Get Alert |
| 11/08/2023 | DNLI | Buy Now | Denali Therapeutics | $23.94 | 29.49% | → $31 | Reiterates | Outperform → Outperform | Get Alert |
| 11/03/2023 | PHVS | Buy Now | Pharvaris | $16.65 | 44.14% | $27 → $24 | Maintains | Outperform | Get Alert |
| 11/03/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | $250 → $253 | Maintains | Outperform | Get Alert |
| 10/31/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.97 | 131.68% | $46 → $37 | Maintains | Outperform | Get Alert |
| 10/26/2023 | BIIB | Buy Now | Biogen | $225.02 | 18.21% | $270 → $266 | Maintains | Neutral | Get Alert |
| 10/13/2023 | ATXS | Buy Now | Astria Therapeutics | $11.84 | 52.03% | $25 → $18 | Maintains | Outperform | Get Alert |
| 10/12/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | $39.50 | -72.15% | → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 10/03/2023 | PRAX | Buy Now | Praxis Precision Medicine | $53.12 | -96.23% | → $30 | Reiterates | Neutral → Neutral | Get Alert |
| 09/29/2023 | TVTX | Buy Now | Travere Therapeutics | $10.22 | 17.42% | → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 09/28/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $85.89 | — | — | Initiates | → Market Perform | Get Alert |
| 09/25/2023 | PHVS | Buy Now | Pharvaris | $16.65 | 62.16% | → $27 | Initiates | → Outperform | Get Alert |
| 09/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $146.02 | -6.18% | $120 → $137 | Maintains | Outperform | Get Alert |
| 09/13/2023 | ARDX | Buy Now | Ardelyx | $6.17 | 13.45% | → $7 | Reiterates | Outperform → Outperform | Get Alert |
| 09/13/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.97 | 188.04% | → $46 | Reiterates | Outperform → Outperform | Get Alert |
| 08/23/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $40.04 | -27.56% | → $29 | Reiterates | Neutral → Neutral | Get Alert |
| 08/16/2023 | EWTX | Buy Now | Edgewise Therapeutics | $22.20 | 21.62% | → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 08/15/2023 | DSGN | Buy Now | Design Therapeutics | $4.55 | 31.87% | → $6 | Downgrade | Outperform → Neutral | Get Alert |
| 08/11/2023 | VERA | Buy Now | Vera Therapeutics | $38.19 | -58.1% | $12 → $16 | Maintains | Neutral | Get Alert |
| 08/11/2023 | EWTX | Buy Now | Edgewise Therapeutics | $22.20 | 21.62% | → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 08/10/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $42.94 | 9.46% | → $47 | Reiterates | Outperform → Outperform | Get Alert |
| 08/09/2023 | DNLI | Buy Now | Denali Therapeutics | $23.94 | 29.49% | $37 → $31 | Maintains | Outperform | Get Alert |
| 08/08/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | → $42 | Downgrade | Outperform → Neutral | Get Alert |
| 08/08/2023 | ATXS | Buy Now | Astria Therapeutics | $11.84 | 111.15% | $26 → $25 | Maintains | Outperform | Get Alert |
| 08/07/2023 | SAGE | Buy Now | Sage Therapeutics | $12.16 | 80.92% | → $22 | Downgrade | Outperform → Neutral | Get Alert |
| 08/07/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $40.04 | -27.56% | $32 → $29 | Maintains | Neutral | Get Alert |
| 07/26/2023 | BIIB | Buy Now | Biogen | $225.02 | 19.1% | $269 → $268 | Maintains | Neutral | Get Alert |
| 07/20/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $40.04 | -0.09% | $86 → $40 | Maintains | Neutral | Get Alert |
| 07/11/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.97 | 181.78% | $48 → $45 | Maintains | Outperform | Get Alert |
| 06/21/2023 | TVTX | Buy Now | Travere Therapeutics | $10.22 | 125.05% | → $23 | Reiterates | Outperform → Outperform | Get Alert |
| 06/20/2023 | PRAX | Buy Now | Praxis Precision Medicine | $53.12 | -96.23% | → $30 | Reiterates | Neutral → Neutral | Get Alert |
| 06/14/2023 | PEPG | Buy Now | PepGen | $18.00 | 22.22% | → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 06/06/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $45.27 | 12.66% | $48 → $51 | Maintains | Neutral | Get Alert |
| 05/31/2023 | PEPG | Buy Now | PepGen | $18.00 | 22.22% | → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 05/23/2023 | BIIB | Buy Now | Biogen | $225.02 | 16.88% | → $263 | Reiterates | Neutral → Neutral | Get Alert |
| 05/12/2023 | ATXS | Buy Now | Astria Therapeutics | $11.84 | 119.59% | → $26 | Reiterates | → Outperform | Get Alert |
| 05/12/2023 | PRAX | Buy Now | Praxis Precision Medicine | $53.12 | -96.23% | → $30 | Reiterates | → Neutral | Get Alert |
| 05/12/2023 | EWTX | Buy Now | Edgewise Therapeutics | $22.20 | 21.62% | → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 05/12/2023 | VERA | Buy Now | Vera Therapeutics | $38.19 | -76.43% | $6 → $9 | Maintains | Neutral | Get Alert |
| 05/10/2023 | DSGN | Buy Now | Design Therapeutics | $4.55 | 317.58% | $20 → $19 | Maintains | Outperform | Get Alert |
| 05/10/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $42.94 | 9.46% | $44 → $47 | Maintains | Outperform | Get Alert |
| 05/10/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | → $36 | Reiterates | → Outperform | Get Alert |
| 05/10/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | $39.50 | -72.15% | → $11 | Reiterates | → Outperform | Get Alert |
| 05/10/2023 | VRDN | Buy Now | Viridian Therapeutics | $15.97 | 200.56% | $46 → $48 | Maintains | Outperform | Get Alert |
| 05/09/2023 | DNLI | Buy Now | Denali Therapeutics | $23.94 | 54.55% | $38 → $37 | Maintains | Outperform | Get Alert |
| 05/08/2023 | RARE | Buy Now | Ultragenyx Pharmaceutical | $45.27 | 6.03% | $47 → $48 | Maintains | Neutral | Get Alert |
| 05/03/2023 | SAGE | Buy Now | Sage Therapeutics | $12.16 | 319.41% | $49 → $51 | Maintains | Outperform | Get Alert |
| 04/26/2023 | BIIB | Buy Now | Biogen | $225.02 | 16.88% | → $263 | Reiterates | → Neutral | Get Alert |
| 04/17/2023 | TVTX | Buy Now | Travere Therapeutics | $10.22 | 183.76% | $30 → $29 | Maintains | Outperform | Get Alert |
| 04/17/2023 | NBIX | Buy Now | Neurocrine Biosciences | $146.02 | -12.34% | $131 → $128 | Maintains | Outperform | Get Alert |
| 04/17/2023 | BIIB | Buy Now | Biogen | $225.02 | 16.88% | $249 → $263 | Maintains | Neutral | Get Alert |
| 04/17/2023 | ARDX | Buy Now | Ardelyx | $6.17 | 13.45% | $6 → $7 | Maintains | Outperform | Get Alert |
| 04/17/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $40.04 | 67.35% | $51 → $67 | Maintains | Neutral | Get Alert |
| 04/10/2023 | RLYB | Buy Now | Rallybio | $1.47 | 1056.38% | → $17 | Initiates | → Outperform | Get Alert |
| 04/03/2023 | VIGL | Buy Now | Vigil Neuroscience | $4.22 | 445.02% | → $23 | Reiterates | → Outperform | Get Alert |
| 03/24/2023 | PEPG | Buy Now | PepGen | $18.00 | 22.22% | $17 → $22 | Maintains | Outperform | Get Alert |
| 03/21/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | — | Maintains | Outperform | Get Alert |
| 03/07/2023 | STOK | Buy Now | Stoke Therapeutics | $14.74 | 69.61% | $33 → $25 | Maintains | Outperform | Get Alert |
| 03/03/2023 | ARDX | Buy Now | Ardelyx | $6.17 | -2.76% | $3 → $6 | Upgrade | Neutral → Outperform | Get Alert |
| 02/28/2023 | DNLI | Buy Now | Denali Therapeutics | $23.94 | 58.73% | $46 → $38 | Maintains | Outperform | Get Alert |
| 02/21/2023 | TVTX | Buy Now | Travere Therapeutics | $10.22 | 193.54% | → $30 | Upgrade | Neutral → Outperform | Get Alert |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $146.02 | -10.29% | $125 → $131 | Maintains | Outperform | Get Alert |
| 01/04/2023 | VERA | Buy Now | Vera Therapeutics | $38.19 | -79.05% | → $8 | Downgrade | Outperform → Neutral | Get Alert |
| 11/30/2022 | BIIB | Buy Now | Biogen | $225.02 | 9.77% | $218 → $247 | Maintains | Neutral | Get Alert |
| 11/15/2022 | IMPL | Buy Now | Impel Pharmaceuticals | — | — | $24 → $5 | Downgrade | Outperform → Neutral | Get Alert |
| 09/28/2022 | BIIB | Buy Now | Biogen | $225.02 | -3.56% | $183 → $217 | Maintains | Neutral | Get Alert |
| 09/16/2022 | VIGL | Buy Now | Vigil Neuroscience | $4.22 | 350.24% | → $19 | Initiates | → Outperform | Get Alert |
| 09/12/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $40.04 | 67.35% | $55 → $67 | Maintains | Neutral | Get Alert |
| 08/12/2022 | TSHA | Buy Now | Taysha Gene Therapies | $2.46 | 103.25% | $9 → $5 | Maintains | Outperform | Get Alert |
| 08/09/2022 | DSGN | Buy Now | Design Therapeutics | $4.55 | 471.43% | $21 → $26 | Maintains | Outperform | Get Alert |
| 08/08/2022 | BHVN | Buy Now | Biohaven | $37.70 | 293.9% | → $148.5 | Downgrade | Outperform → Neutral | Get Alert |
| 06/27/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $42.94 | -4.52% | $47 → $41 | Maintains | Outperform | Get Alert |
| 06/10/2022 | DSGN | Buy Now | Design Therapeutics | $4.55 | 361.54% | → $21 | Initiates | → Outperform | Get Alert |
| 05/31/2022 | PEPG | Buy Now | PepGen | $18.00 | -5.56% | → $17 | Initiates | → Outperform | Get Alert |
| 04/19/2022 | VERA | Buy Now | Vera Therapeutics | $38.19 | -16.21% | → $32 | Initiates | → Outperform | Get Alert |
| 02/14/2022 | LBPH | Buy Now | Longboard Pharmaceuticals | $39.50 | -64.56% | → $14 | Initiates | → Outperform | Get Alert |
| 01/12/2022 | BIIB | Buy Now | Biogen | $225.02 | -13.34% | $249 → $195 | Maintains | Neutral | Get Alert |
| 04/21/2017 | CDTX | Buy Now | Cidara Therapeutics | $12.16 | 15.13% | → $280 | Initiates | → Strong Buy | Get Alert |
